Back to
Frontier Capital Management Co. LLC
KYMR
9 quarters
Position history for
Frontier Capital Management Co. LLC's holdings in Kymera Therapeutics, Inc.
Yes. Frontier Capital Management holds 564,133 shares of KYMR (Kymera Therapeutics), worth $63.1M, as of its Q3 2026 13F filing. It reduced the position by 176,733 shares (-23.9%) from Q2 2026. Frontier Capital Management has held KYMR since Q3 2024, across 9 quarterly 13F filings. KYMR is 0.7% of Frontier Capital Management's reported 13F portfolio.
Current Value
$63.1M
Current Shares
564,133
Total Value Change
+$44.5M
Total Shares Change
+171,870
Quarter-by-Quarter History
Other major holders of KYMR: FMR LLC, Baker Bros. Advisors LP, T. Rowe Price Associates, Inc.